SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-054346
Filing Date
2023-05-01
Accepted
2023-05-01 16:06:22
Documents
6
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm232157-2_def14a.htm DEF 14A 747256
2 GRAPHIC lg_checkpointthera-4c.jpg GRAPHIC 168247
3 GRAPHIC sg_jamesfoliviero-bw.jpg GRAPHIC 10884
4 GRAPHIC sg_garrettgray-bw.jpg GRAPHIC 9851
5 GRAPHIC px_01pgprxy-bw.jpg GRAPHIC 681765
6 GRAPHIC px_02pgprxy-bw.jpg GRAPHIC 789248
  Complete submission text file 0001104659-23-054346.txt   2737973
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38128 | Film No.: 23873586
SIC: 2834 Pharmaceutical Preparations